Sign in
HROWM Stock Price, Chart, Stats & News
Harrow Health, Inc. 11.875% Senior Notes due 2027
Save
Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) does not currently pay a dividend.
1.34B
Market cap
–
Current P/E
–
Forward P/E
HROWM chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 75.05% |
Operating margin | 11.21% |
Pretax margin | -3.27% |
Net margin | -1.89% |
Effective tax rate | 42.32% |
ROA | -1.29% |
ROE | -10.00% |
D/E | 4.80x |
Interest coverage ratio | 1.26x |
HROWM valuation
P/E | – |
P/S | 4.63x |
P/B | 23.71x |
P/CF | 28.35x |
P/FCF | 29.33x |
P/OCF | 28.35x |
PEG | 33.88x |
EV multiple | 28.37x |
About
Harrow Health, Inc. focuses on the creation, production, and marketing of cutting-edge pharmaceutical solutions. Its business activities are primarily organized into two distinct divisions: Pharmaceutical Compounding and Pharmaceutical Drug Development. Specifically, the Pharmaceutical Compounding segment oversees the operations of the ImprimisRx enterprise.
Similar securities
Based on sector and market capitalization
Report issue